LogoLogoLogoLogoLogo
  • Portfolio
    • Portfolio Companies
    • Portfolio Jobs
  • News
    • In the News
    • Portfolio News
    • Press Releases
  • About Us
    • Our Team
    • Contact Us
    • About McKesson
  • Portfolio
    • Portfolio Companies
    • Portfolio Jobs
  • News
    • In the News
    • Portfolio News
    • Press Releases
  • About Us
    • Our Team
    • Contact Us
    • About McKesson

McKesson Ventures Joins Series C Round for Evariant May 10, 2016

McKesson Ventures Joins Series C Round for Evariant Evariant

Subscribe to McKesson Ventures

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

McKesson Ventures

We partner with companies that are driving and enabling positive change for key stakeholders on all sides of the health care economy.

Find out more about McKesson

Portfolio News

  • Evidation Raises $45 Million Series D, Hires CCO To Accelerate Commercial Momentum and Expand Into Virtual Health

  • New Survey Reveals Patients Have Been Overwhelmingly Satisfied with Virtual Care During the COVID-19 Pandemic and Want Greater Access to it in the Future

  • Planned Parenthood asks companies to pledge to guarantee employee birth control coverage

  • Accolade sets terms for IPO, aims to raise up to $211M in Seattle’s first public offering this year

McKesson Ventures News

  • McKesson Appoints Tom Rodgers to Executive Vice President & Chief of Strategy and Business Development Officer
  • Real-World Evidence Should Be Part of Clinical Trials in Oncology
  • McKesson Ventures’ Carrie Hurwitz Williams Recognized as GCV Rising Star
  • Matternet Raises Strategic Investment from McKesson Ventures
2015 McKesson Ventures | Privacy Notice | Disclaimer
@McK_Ventures
McKesson Ventures LinkedIn